<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 23 year old man with severe idiopathic <z:mpath ids='MPATH_58'>aplasia</z:mpath>, who had previously been unsuccessfully treated with oxymetholone for a period of 6 months, received two intravenous (IV) infusions of bone marrow cells from his HLA identical brother </plain></SENT>
<SENT sid="1" pm="."><plain>He was given 200 mg/kg anti-lymphocyte globulins (ALG) IV, followed by a first infusion of 13 X 10(9) nucleated cells IV, but no improvement was observed </plain></SENT>
<SENT sid="2" pm="."><plain>Three months later, he was treated with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (25 mg/kg over 4 days) followed by a second infusion of 18 X 10(9) nucleated cells IV of the same donor </plain></SENT>
<SENT sid="3" pm="."><plain>Within a four month period there was evidence of complete marrow reconstitution, and the patient has experienced no relapse of the disease during the subsequent 13 years follow up period </plain></SENT>
<SENT sid="4" pm="."><plain>The mechanism of the recovery is unclear: no evidence of graft acceptance could be established </plain></SENT>
<SENT sid="5" pm="."><plain>The respective roles of ALG, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and/or bone marrow infusions are discussed </plain></SENT>
</text></document>